The study of Clonidine as an adjuvant to Levobupivacaine in supraclavicular block
Phase 4
Completed
- Conditions
- Health Condition 1: null- ASA 1,ASA 2 patients were included in the study
- Registration Number
- CTRI/2018/02/011888
- Lead Sponsor
- Dr KF Kammar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
ASA 1 and ASA 2 patients scheduled for elective upper limb surgeries
Exclusion Criteria
patient refusal
Allergy to trial drugs
Clavicular fracture
Skin infection at needle insertion site
Morbid obesity
Patients with coagulopathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of postoperative analgesiaTimepoint: Duration of postoperative analgesia
- Secondary Outcome Measures
Name Time Method Duration of motor blockTimepoint: Time interval between the end of drug administration and the complete recovery of motor function of upper limb;Duration of sensory blockTimepoint: Time interval between onset of sensory anaesthesia and the complete resolution of anaesthesia on all nerves;Onset of Motor BlockTimepoint: Time taken from completion of injection of study drug to the maximum motor block attained;Onset of sensory blockadeTimepoint: Time taken from completion of injection of study drug to the first loss of pin prick sensation in C5-T1 dermatome using a blunt needle;Quality of blockTimepoint: Grade 4: No complaint from patient <br/ ><br>Grade 3: Minor complaint with no need of supplemental analgesics <br/ ><br>Grade 2: Complaint that required supplemental analgesics <br/ ><br>Grade 1:Patient given general anaesthesia